OS2966 DRAMATICALLY ENHANCES PRECLINICAL EFFICACY OF ONCOLYTIC VIRUS THERAPY

被引：0
|
作者：
Carbonell, Shawn [1 ]
Yoo, Ji Young [2 ]
Nallanagulagari, Tejaswini [2 ,3 ]
Jaime-Ramirez, Alena Cristina [2 ]
Bolyard, Chelsea [2 ]
Lee, Tae Jin [4 ]
Zhang, Jianying [5 ]
Croce, Carlo [4 ]
Wu, Eric [1 ]
Aghi, Manish [6 ]
Kaur, Balveen [2 ]
机构：
[1] OncoSynergy Inc, San Francisco, CA USA
[2] Ohio State Univ, Coll Med, Dept Neurol Surg, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA
[3] Ohio State Univ, Biochem & Microbiol Majors, Columbus, OH 43210 USA
[4] Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[5] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA
[6] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-33
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [31] Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
    Matuszewska, Kathy
    Santry, Lisa A.
    van Vloten, Jacob P.
    AuYeung, Amanda W. K.
    Major, Pierre P.
    Lawler, Jack
    Wootton, Sarah K.
    Bridle, Byram W.
    Petrik, Jim
    CLINICAL CANCER RESEARCH, 2019, 25 (05) : 1624 - 1638
  • [32] Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
    Rahman, Masmudur M.
    van Oosterom, Fleur
    Enow, Junior A.
    Hossain, Maksuda
    Gutierrez-Jensen, Ami D.
    Cashen, Mackenzie
    Everts, Anne
    Lowe, Kenneth
    Kilbourne, Jacquelyn
    Daggett-Vondras, Juliane
    Karr, Timothy L.
    McFadden, Grant
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (06): : 952 - 968
  • [33] Combination Therapies to Reverse Tumor Antiviral Immunity Enhances Vesicular Stomatitis Virus Oncolytic Efficacy
    Maroun, Justin Walter
    Penza, Velia
    Schulze, Autumn J.
    Russell, Stephen J.
    MOLECULAR THERAPY, 2020, 28 (04) : 162 - 163
  • [34] Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model
    Bazan-Peregrino, Miriam
    Arvanitis, Costas D.
    Rifai, Bassel
    Seymour, Leonard W.
    Coussios, Constantin-C.
    JOURNAL OF CONTROLLED RELEASE, 2012, 157 (02) : 235 - 242
  • [35] Expression of SIRPα-Fc by oncolytic virus enhances antitumor efficacy through tumor microenvironment reprogramming
    Yang, Qingzhe
    Shu, Yongheng
    Chen, Yanwei
    Qi, Zhongbing
    Hu, Shichuan
    Zhang, Yao
    Qin, Yu
    Xu, Xianglin
    Hu, Jianchuan
    Huang, Anliang
    Cheng, Ping
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [36] Antiangiogenic Arming of an Oncolytic Vaccinia Virus Enhances Antitumor Efficacy in Renal Cell Cancer Models
    Guse, Kilian
    Sloniecka, Marta
    Diaconu, Iulia
    Ottolino-Perry, Kathryn
    Tang, Nan
    Ng, Calvin
    Le Boeuf, Fabrice
    Bell, John C.
    McCart, J. Andrea
    Ristimaki, Ari
    Pesonen, Sari
    Cerullo, Vincenzo
    Hemminki, Akseli
    JOURNAL OF VIROLOGY, 2010, 84 (02) : 856 - 866
  • [37] Oncolytic virus treatment of human breast cancer cells: Modelling therapy efficacy
    Sherlock, Brock D.
    Coster, Adelle C. F.
    JOURNAL OF THEORETICAL BIOLOGY, 2023, 560
  • [38] An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
    Ye, Kai
    Li, Fan
    Wang, Ruikun
    Cen, Tianyi
    Liu, Shiyu
    Zhao, Zhuoqian
    Li, Ruonan
    Xu, Lili
    Zhang, Guanmeng
    Xu, Zhaoyuan
    Deng, Li
    Li, Lili
    Wang, Wei
    Stepanov, Alexey
    Wan, Yajuan
    Guo, Yu
    Li, Yuanke
    Wang, Yuan
    Tian, Yujie
    Gabibov, Alexander G.
    Yan, Yingbin
    Zhang, Hongkai
    MOLECULAR THERAPY, 2022, 30 (12) : 3658 - 3676
  • [39] The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus
    Fujii, K.
    Kurozumi, K.
    Ichikawa, T.
    Onishi, M.
    Shimazu, Y.
    Ishida, J.
    Chiocca, E. A.
    Kaur, B.
    Date, I.
    CANCER GENE THERAPY, 2013, 20 (08) : 437 - 444
  • [40] GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution
    S Guedan
    D Grases
    J J Rojas
    A Gros
    F Vilardell
    R Vile
    E Mercade
    M Cascallo
    R Alemany
    Gene Therapy, 2012, 19 : 1048 - 1057
12345